Objective: To investigate the role of γδ T cells in the regulation of immune response in Plasmodium falciparum infection. Methods: γδ and αβ T cells were purified from peripheral mononuclear blood cells (PMBC) by positive selection method using monoclonal antibodies. The PMBC were obtained from normal healthy donors. The role of various T cell subsets was investigated by observing their capacity to inhibit the growth of P. falciparum parasites. Results: By positive selection using monoclonal antibodies we were able to obtain a relatively pure fraction (>95%) of γδ T cells from PMBC. The parasite growth inhibitory capacity of activated γδ T cells ranged between 6 and 55%, however, activated αβ T cells failed to inhibit the growth. It was also observed that the inhibitory capacity of γδ T cells was dose-dependent and required physical contact with the organism. Conclusion: Activated γδ T cells have the capacity to inhibit the growth of P. falciparum parasites and thus may act as a first line of defense in controlling the blood stage infection. The significance of γδ T cells in influencing various bacterial infections is discussed.

Keywords:
γδ T cells, Infectious diseases, Lymphocytes, Malaria
This content is only available via PDF.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.